UNSPSC 51432111: Guanethidine sulfate

This classification denotes an antihypertensive agent with the molecular formula 2C10H22N4.H2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8AQ60474G9, chemically known as 2-(1-n,n-heptamethyleneimino)ethylguanidine but more generally known as guanethidine sulfate, which bears US NIH Compound Identifier 3518. European Medicines Agency schedules Guanethidine sulfate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB02426MIG.

Most nations, for tariff and trade purposes, schedule guanethidine sulfate under HS 29339990 and SITC 51577. As of Q4 2014, GUANETHIDINE SULFATE remains US FDA's Preferred Term for this commodity. Guanethidine sulfate bears US NLM identifiers UMLS ID C0700538 and NCI Concept Code C80000. SMILES: C1CCCN(CCC1)CCNC(=N)N.C1CCCN(CCC1)CCNC(=N)N.OS(=O)(=O)O.

UNSPSC 51432111 Guanethidine sulfate is a Commodity code that captures state and local procurement of emergency medical medications for advanced life support. The recent opportunity record shows that state and local governments use this code to solicit individual pharmaceutical products—in this case, emergency cardiac and vasopressor medications—for fire rescue and emergency medical services operations. The solicitation from the City of Tampa's Purchasing Department specifies four medication line items including labetalol, epinephrine, adenosine, and diltiazem, all required to meet expiration-date and warranty standards and to comply with OSHA and federal accessibility regulations. Issuing bodies procuring under this code include municipal fire departments and emergency medical services divisions; the Tampa opportunity reflects procurement through a city purchasing office on behalf of an operational fire rescue agency.

The City of Tampa issued IFB 26P00188 for Advanced Life Support Medications in April 2026 with a response deadline of April 8, 2026 and an estimated contract value of $40,000.00. The Tampa solicitation carried a Small Local Business Enterprise sheltered-market designation with a 5 percent bid discount for SLBE participation, required delivery within ten calendar days of order receipt, and a one-year contract term with two optional renewal periods plus unilateral extension rights for three additional 30-day periods. The code shows limited recent posting activity in the dataset; no other state or local opportunities appear under this specific commodity code in the source material, suggesting either narrow or infrequent procurement demand for guanethidine sulfate specifically, or that jurisdictions are tagging pharmaceutical procurements under broader medication or medical-supply codes rather than individual active-ingredient commodity codes.